Nandini Mukhopadhyay Meyersohn, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Angiography | 19 | 2022 | 4576 | 1.510 |
Why?
|
Coronary Artery Disease | 18 | 2024 | 6486 | 1.050 |
Why?
|
Chest Pain | 12 | 2022 | 1114 | 0.630 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2017 | 168 | 0.550 |
Why?
|
Cardiology Service, Hospital | 1 | 2017 | 246 | 0.500 |
Why?
|
Coronary Stenosis | 4 | 2022 | 834 | 0.460 |
Why?
|
Thoracic Diseases | 1 | 2014 | 97 | 0.460 |
Why?
|
Hospitals, General | 1 | 2016 | 749 | 0.400 |
Why?
|
Iatrogenic Disease | 1 | 2014 | 547 | 0.390 |
Why?
|
Predictive Value of Tests | 15 | 2022 | 15078 | 0.340 |
Why?
|
Plaque, Atherosclerotic | 4 | 2024 | 1519 | 0.330 |
Why?
|
Radiography, Thoracic | 2 | 2016 | 1265 | 0.330 |
Why?
|
Coronary Vessels | 6 | 2022 | 3107 | 0.270 |
Why?
|
Societies, Medical | 6 | 2022 | 3743 | 0.250 |
Why?
|
Peripheral Arterial Disease | 1 | 2015 | 1188 | 0.250 |
Why?
|
Pericardium | 2 | 2020 | 667 | 0.250 |
Why?
|
Emergency Service, Hospital | 4 | 2022 | 7658 | 0.250 |
Why?
|
Myocardial Infarction | 4 | 2022 | 11718 | 0.220 |
Why?
|
Tomography, X-Ray Computed | 8 | 2024 | 20130 | 0.200 |
Why?
|
Cardiac Volume | 1 | 2021 | 210 | 0.180 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 289 | 0.180 |
Why?
|
Quinolines | 1 | 2024 | 732 | 0.170 |
Why?
|
Adipose Tissue | 3 | 2020 | 3280 | 0.160 |
Why?
|
Vascular Diseases | 2 | 2018 | 1161 | 0.160 |
Why?
|
Nitroglycerin | 1 | 2019 | 325 | 0.160 |
Why?
|
Thoracic Injuries | 1 | 2020 | 272 | 0.160 |
Why?
|
Prognosis | 9 | 2022 | 29060 | 0.150 |
Why?
|
Endocarditis | 1 | 2021 | 349 | 0.140 |
Why?
|
Relative Biological Effectiveness | 1 | 2018 | 323 | 0.140 |
Why?
|
Diagnostic Imaging | 5 | 2022 | 3508 | 0.130 |
Why?
|
Coronary Aneurysm | 1 | 2018 | 237 | 0.130 |
Why?
|
Syncope | 1 | 2018 | 429 | 0.130 |
Why?
|
Coronary Care Units | 1 | 2016 | 214 | 0.130 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2017 | 153 | 0.130 |
Why?
|
Saphenous Vein | 1 | 2018 | 532 | 0.130 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 551 | 0.130 |
Why?
|
Middle Aged | 24 | 2024 | 213390 | 0.130 |
Why?
|
Vasodilation | 1 | 2019 | 944 | 0.130 |
Why?
|
Vasodilator Agents | 1 | 2019 | 976 | 0.120 |
Why?
|
Aorta | 2 | 2021 | 2062 | 0.120 |
Why?
|
Coronary Vessel Anomalies | 1 | 2018 | 314 | 0.120 |
Why?
|
Aortic Valve Insufficiency | 1 | 2018 | 579 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2017 | 266 | 0.120 |
Why?
|
Photons | 1 | 2018 | 588 | 0.120 |
Why?
|
Wounds, Nonpenetrating | 1 | 2020 | 795 | 0.120 |
Why?
|
Pulmonary Fibrosis | 1 | 2018 | 530 | 0.120 |
Why?
|
Acute Coronary Syndrome | 2 | 2017 | 2337 | 0.120 |
Why?
|
Foramen Ovale, Patent | 1 | 2016 | 223 | 0.110 |
Why?
|
Triage | 2 | 2018 | 977 | 0.110 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2014 | 194 | 0.110 |
Why?
|
Academic Medical Centers | 2 | 2024 | 2760 | 0.110 |
Why?
|
Incidental Findings | 1 | 2017 | 689 | 0.110 |
Why?
|
Evidence-Based Medicine | 2 | 2021 | 3611 | 0.110 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2018 | 851 | 0.110 |
Why?
|
Humans | 39 | 2024 | 744366 | 0.100 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2018 | 691 | 0.100 |
Why?
|
Registries | 5 | 2018 | 8091 | 0.100 |
Why?
|
Male | 24 | 2024 | 350115 | 0.100 |
Why?
|
Practice Guidelines as Topic | 3 | 2018 | 7282 | 0.100 |
Why?
|
Cardiology | 1 | 2022 | 1668 | 0.100 |
Why?
|
Observer Variation | 1 | 2017 | 2593 | 0.090 |
Why?
|
Heart Ventricles | 2 | 2020 | 3817 | 0.090 |
Why?
|
Foreign Bodies | 1 | 2014 | 400 | 0.090 |
Why?
|
Acupuncture Therapy | 1 | 2014 | 464 | 0.090 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2017 | 1184 | 0.090 |
Why?
|
Constriction, Pathologic | 2 | 2024 | 1107 | 0.090 |
Why?
|
Prospective Studies | 10 | 2022 | 53290 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3255 | 0.080 |
Why?
|
Catheterization | 1 | 2014 | 1470 | 0.080 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2288 | 0.080 |
Why?
|
Pacemaker, Artificial | 1 | 2014 | 816 | 0.080 |
Why?
|
Equipment Design | 1 | 2017 | 3582 | 0.080 |
Why?
|
Radiation Dosage | 1 | 2017 | 1928 | 0.080 |
Why?
|
Cardiac-Gated Imaging Techniques | 2 | 2019 | 143 | 0.080 |
Why?
|
Radiology | 1 | 2022 | 2099 | 0.080 |
Why?
|
Risk Assessment | 8 | 2022 | 23336 | 0.080 |
Why?
|
Surgery, Plastic | 1 | 2014 | 624 | 0.080 |
Why?
|
Female | 20 | 2024 | 380193 | 0.080 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15160 | 0.080 |
Why?
|
North America | 2 | 2022 | 1249 | 0.070 |
Why?
|
Risk Factors | 7 | 2022 | 72296 | 0.070 |
Why?
|
Probability | 2 | 2022 | 2506 | 0.070 |
Why?
|
Hypertension, Pulmonary | 1 | 2016 | 1534 | 0.070 |
Why?
|
Heart | 1 | 2018 | 4464 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4561 | 0.060 |
Why?
|
Pulmonary Embolism | 1 | 2016 | 2375 | 0.060 |
Why?
|
United States | 8 | 2022 | 69872 | 0.060 |
Why?
|
Aged | 10 | 2022 | 163288 | 0.050 |
Why?
|
Massachusetts | 1 | 2016 | 8662 | 0.050 |
Why?
|
Lung | 2 | 2018 | 9857 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2019 | 77460 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2017 | 19905 | 0.050 |
Why?
|
Cohort Studies | 2 | 2022 | 40559 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2014 | 2758 | 0.050 |
Why?
|
Lipoproteins, LDL | 1 | 2024 | 640 | 0.050 |
Why?
|
Electrocardiography | 3 | 2019 | 6442 | 0.050 |
Why?
|
Administration, Sublingual | 1 | 2019 | 56 | 0.040 |
Why?
|
Transdermal Patch | 1 | 2019 | 51 | 0.040 |
Why?
|
Tablets | 1 | 2019 | 145 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13286 | 0.040 |
Why?
|
Troponin | 1 | 2022 | 524 | 0.040 |
Why?
|
Troponin I | 1 | 2022 | 619 | 0.040 |
Why?
|
HIV Infections | 1 | 2024 | 16715 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2019 | 711 | 0.040 |
Why?
|
Angiography | 1 | 2022 | 1639 | 0.040 |
Why?
|
Aerosols | 1 | 2019 | 625 | 0.040 |
Why?
|
Acute Disease | 2 | 2017 | 7147 | 0.030 |
Why?
|
Thoracic Wall | 1 | 2018 | 203 | 0.030 |
Why?
|
Hypotension, Orthostatic | 1 | 2018 | 255 | 0.030 |
Why?
|
Adult | 6 | 2018 | 214052 | 0.030 |
Why?
|
Heart Failure | 1 | 2018 | 10895 | 0.030 |
Why?
|
Echocardiography | 2 | 2018 | 5099 | 0.030 |
Why?
|
Radiotherapy, Conformal | 1 | 2018 | 548 | 0.030 |
Why?
|
Bundle-Branch Block | 1 | 2016 | 270 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2019 | 680 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 923 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 21696 | 0.030 |
Why?
|
Inflammation | 2 | 2024 | 10637 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 2960 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1516 | 0.030 |
Why?
|
Echocardiography, Transesophageal | 1 | 2018 | 1133 | 0.030 |
Why?
|
Back Pain | 1 | 2016 | 545 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3203 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12961 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 35425 | 0.030 |
Why?
|
Minority Groups | 1 | 2019 | 1221 | 0.030 |
Why?
|
Pulmonary Emphysema | 1 | 2016 | 672 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2018 | 1223 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1806 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12025 | 0.020 |
Why?
|
Calcium | 1 | 2022 | 5755 | 0.020 |
Why?
|
Aortic Valve | 1 | 2018 | 1924 | 0.020 |
Why?
|
Dyspnea | 1 | 2016 | 1303 | 0.020 |
Why?
|
Ultrasonography | 1 | 2021 | 5984 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2018 | 2265 | 0.020 |
Why?
|
Inpatients | 1 | 2019 | 2518 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2018 | 2148 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2016 | 1580 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9312 | 0.020 |
Why?
|
Heart Diseases | 1 | 2018 | 2789 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2019 | 57776 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16367 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8385 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15221 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9145 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15535 | 0.010 |
Why?
|
Adolescent | 2 | 2018 | 85779 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39052 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 56429 | 0.010 |
Why?
|
Animals | 1 | 2024 | 168768 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 63107 | 0.010 |
Why?
|